Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MIF | P14174 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1047388 | 0.93 | CYP2C19 (0.35) | CYP2C19LMNAALOX15KDM4ECYP3A4 | |
| Formic Acid SCHEMBL1162475 | 0.90 | CYP2D6 (0.35) | CYP2C19LMNAALOX15KDM4ECYP3A4 | |
| Phosphonic Acid SCHEMBL1162520 | 0.88 | CYP2C19 (0.34) | CYP2C19LMNAALOX15KDM4ECYP3A4 | |
| SCHEMBL28429021 | 0.88 | CYP2C19 (0.34) | CYP2C19LMNAALOX15KDM4ECYP3A4 | |
| SCHEMBL5800479 | 0.80 | PGK1 (0.31) | — | |
| SCHEMBL29812875 | 0.74 | CYP2D6 (0.35) | LMNATSHRCYP2D6SRCMIF | |
| SCHEMBL6889278 | 0.74 | MIF (0.34) | CYP2C19ALOX15KDM4ECYP3A4MAPT | |
| SCHEMBL4443347 | 0.74 | MIF (0.52) | CYP2C19ALOX15KDM4ECYP3A4MAPT | |
| SCHEMBL1563451 | 0.74 | TRPA1 (0.36) | LMNACYP2D6SRCHPGDKMT2A | |
| SCHEMBL3519342 | 0.71 | MIF (0.36) | MEN1KMT2AMIF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230256413-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | WATERS TECHNOLOGIES CORPORATION (US) | 2023-08-17 | — | — | US | disclosed |
| EP-4129466-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | Waters Technologies Corporation (US) | 2023-02-08 | — | — | EP | disclosed |
| US-20210220753-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2021-07-22 | — | — | US | disclosed |
| US-10974167-B2 | High purity chromatographic materials comprising an ionizable modifier | WATERS TECHNOLOGIES CORPORATION (US) | 2021-04-13 | — | — | US | disclosed |
| EP-2714225-B1 | METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS | WATERS TECHNOLOGIES CORP (US) | 2020-11-11 | — | — | EP | disclosed |
| US-20200332028-A1 | CHARGED SURFACE REVERSED PHASE CHROMATOGRAPHIC MATERIALS METHOD FOR ANALYSIS OF GLYCANS MODIFIED WITH AMPHIPATHIC, STRONGLY BASIC MOIETIES | WATERS TECHNOLOGIES CORPORATION | 2020-10-22 | — | — | US | disclosed |
| EP-3687652-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | Waters Technologies Corporation (US) | 2020-08-05 | — | — | EP | disclosed |
| US-20190134604-A1 | POROUS MATERIALS WITH CONTROLLED POROSITY; PROCESS FOR THE PREPARATION THEREOF; AND USE THEREOF FOR CHROMATOGRAPHIC SEPARATIONS | WATERS TECHNOLOGIES CORPORATION | 2019-05-09 | — | — | US | disclosed |
| US-20190126241-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER FOR RETENTION OF ACIDIC ANALYTES | WATERS TECHNOLOGIES CORPORATION | 2019-05-02 | — | — | US | disclosed |
| US-20190091606-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2019-03-28 | — | — | US | disclosed |
| US-20170242028-A1 | METHODS FOR QUANTIFYING POLYPEPTIDES USING MASS SPECTROMETRY | WATERS TECHNOLOGIES CORPORATION | 2017-08-24 | — | — | US | disclosed |
| US-9588130-B2 | Methods for quantifying polypeptides using mass spectrometry | WATERS TECHNOLOGIES CORPORATION (US) | 2017-03-07 | — | — | US | disclosed |
| US-20150087073-A1 | METHODS FOR QUANTIFYING POLYPEPTIDES USING MASS SPECTROMETRY | WATERS TECHNOLOGIES CORPORATION | 2015-03-26 | — | — | US | disclosed |
| US-20140338429-A1 | METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2014-11-20 | — | — | US | disclosed |
| US-20130319086-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2013-12-05 | — | — | US | disclosed |
| WO-2013158277-A1 | METHODS FOR QUANTIFYING POLYPEPTIDES USING MASS SPECTROMETRY | WATERS TECHNOLOGIES CORPORATION (US) | 2013-10-24 | — | — | WO | disclosed |
| WO-2012166916-A1 | METHOD OF SEPARATION OF LIPID AND BIOLOGICAL MOLECULAR SPECIES USING HIGH PURITY CHROMATOGRAPHIC MATERIALS | WATERS TECHNOLOGIES CORPORATION (US) | 2012-12-06 | — | — | WO | disclosed |
| US-20120273404-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2012-11-01 | — | — | US | disclosed |
| EP-2462188-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | Waters Technologies Corporation (US) | 2012-06-13 | — | — | EP | disclosed |
| WO-2011017418-A1 | HIGH PURITY CHROMATROGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | WATERS TECHNOLOGIES CORPORATION (US) | 2011-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120273404-A1 | HIGH PURITY CHROMATOGRAPHIC MATERIALS COMPRISING AN IONIZABLE MODIFIER | SPECC1L, SAMM50, RAB5IF | CYP2C19 1101/4885LMNA 614/4885ALOX15 2391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.